Anuh Pharma (506260) Q4 98/99 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 98/99 earnings summary
23 Oct, 2026Executive summary
FY1998-99 profit improved despite lower sales and operating income; cost control supported stronger profitability.
Profit before tax rose to Rs 210.88 lakh from Rs 159.86 lakh; profit after tax increased to Rs 160.88 lakh from Rs 129.86 lakh.
Financial highlights
Sales and operating income were Rs 124.82m versus Rs 166.27m; total income was Rs 130.52m versus Rs 169.36m.
Other income increased to Rs 56.94 lakh from Rs 30.91 lakh, including net interest income of Rs 45.93 lakh versus Rs 26.31 lakh.
Materials, stores and tools consumed fell to Rs 913.24 lakh from Rs 1,398.26 lakh; manufacturing and administrative expenses rose to Rs 144.39 lakh from Rs 112.93 lakh.
Outlook and guidance
Export sales promotion planned to drive a sizeable increase in export turnover; satisfactory turnover and profits expected in FY1999-2000, barring unforeseen circumstances.
Latest events from Anuh Pharma
- Sales and exports grew as the new Tarapur API facility came on stream.506260
Q4 06/07 - Profit rose despite weaker sales; a 1:1 bonus issue and 50% dividend were proposed.506260Q4 97/98
- Sales rose 50% and exports climbed to Rs 99.03m as PAT reached Rs 24.34m.506260Q4 99/00
- PAT rose to ₹39.80m as exports grew and Tarapur capacity expansion began.506260Q4 01/02
- Sales grew 11.6%, exports surged, and PAT softened; dividend rose to ₹12.50/share.506260Q4 02/03
- Sales rose 50.1%, exports 46.5%, and PAT reached Rs 60.3m in FY04.506260Q4 03/04
- Profit fell amid export weakness; a new factory targets ~70% more capacity.506260Q4 04/05
- Sales rose 49.14%, PAT grew 41.57%, and the new factory came on stream.506260Q4 05/06
- FY08 sales rose 35%, PAT grew 13.29%, and 150 MT of capacity was planned.506260Q4 07/08